Table 3.
ADAPT+TAU (n = 40) |
TAU (n = 39) |
|
---|---|---|
Sex | ||
Female | 20 | 27 |
Male | 20 | 12 |
Age M (SD) | 11.67 (1.58) | 11.74 (1.94) |
Race | ||
Caucasian | 35 | 38 |
Asian American | 0 | 0 |
American Indian | 0 | 1 |
African American | 3 | 0 |
Biracial | 1 | 0 |
Other | 1 | 0 |
Ethnicity | ||
Hispanic/Latino | 1 | 1 |
Pain Diagnosis | ||
FAPD-NOS | 25 | 20 |
IBS | 14 | 17 |
Functional Dyspepsia | 0 | 1 |
Abdominal Migraine | 1 | 1 |
Participating Caregiver | ||
Mother | 33 | 31 |
Father | 4 | 3 |
Grandmother | 3 | 2 |
Grandfather | 0 | 1 |
Foster Parent | 0 | 2 |
Caregiver High School Completion | ||
Mother | 40 | 39 |
Father | 37 | 38 |
Caregiver Reported Chronic Pain | ||
Mother | 9 | 16 |
Father | 3 | 11 |
Caregiver Symptoms at Baseline | ||
DASS M (SD) | 3.54 (4.28) | 3.81 (4.31) |
Child Symptoms at Baseline | ||
VAS M (SD) | 3.86 (2.06) | 3.64 (1.64) |
FDI M (SD) | 19.85 (8.74) | 15.78 (7.05) |
SCARED M (SD) | 34.00 (18.19) | 35.87 (12.71) |
Caregiver Symptoms at Post | ||
DASS M (SD) | 2.49 (3.29) | 3.71 (4.40) |
VAS M (SD) | 2.50 (2.10) | 3.00 (2.36) |
FDI M (SD) | 10.20 (8.91) | 12.49 (10.02) |
SCARED M (SD) | 22.02 (16.39) | 29.00 (16.20) |
Note. Analyses were conducted to determine if demographic or clinical symptom differences were present at baseline between randomization groups. No significant differences in demographics between groups were detected (all χ2s < 3.03, ps > .082, t = 0.17, p = .863), aside from father’s pain history (χ2 = 5.34, p = 0.021). Children assigned to ADAPT+TAU reported higher functional disability at baseline (t = −2.25, p = .027). Groups did not differ on any other clinical symptoms at baseline.
ADAPT = Aim to Decrease Anxiety and Pain Treatment; TAU = Treatment as Usual; FAPD-NOS = Functional Abdominal Pain Disorder-Not Otherwise Specified; IBS = Irritable Bowel Syndrome; DASS = Depression Anxiety and Stress Scales, assesses caregiver report of anxiety symptoms; VAS = Visual Analog Scale; FDI = Functional Disability Inventory; SCARED = Screen for Child Anxiety Related Disorders.